National Academies Press: OpenBook
« Previous: Appendix E.4: Skolkovo Institute of Science and Technology
Suggested Citation:"Appendix E.5: Rusnano and Other Russian Investors." National Research Council. 2013. The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions. Washington, DC: The National Academies Press. doi: 10.17226/18277.
×

Appendix E.5

Rusnano and Other Russian Investors

Rusnano is a Russian state-owned equity and venture capital fund. It was set up in 2007 as a state-owned corporation with an investment level of $9 billion, but reorganized in 2011 as a joint-stock company. It has a mandate to develop the nanotech industry in Russia by investing in companies in order to develop and commercialize nanotech-based products in Russia with the goal of nanotech sales reaching $40 billion by 2015. As of June 2012, approximately 20 percent of the funds were to be directed to projects in the life sciences.

Investments and commitments by Rusnano and other Russian investors in biotech activities have been announced as follows:

1: Investments in Venture Funds by Russian Organizations:

Venture Fund/Location/Investor/Fund Value

Domain Associates/U.S./Rusnano (50%)/$760 million

Burrill Capital Fund IV/U.S./Rusnano (40%)/$500 million

Maxwell Biotech/U.S.-Russia/Russian Venture Company/$100 million

RVC Intrafund/Russia/Russian Venture Company/$68 million

RVC Biofund/Russian Venture Company/$50 million

2: Russian Investments in Companies:

Company/Location/Investor/Commitment

ProBonoBil U.K./Russia/Rusnano/$300 million

Nearmedic Plus/Russia/Rusnano/$41 million

Magnisense/France/Rusnano/$38 million

SynBio/Russia/Rusnano/$31 million

Panacela Laboratories/U.S./Rusnano/$26 million

Suggested Citation:"Appendix E.5: Rusnano and Other Russian Investors." National Research Council. 2013. The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions. Washington, DC: The National Academies Press. doi: 10.17226/18277.
×

BIND Biosciences/U.S./Rusnano/$25 million

Selecta Biosciences/U.S./Rusnano/$25 million

BIOptics/U.S./Rusnano/$5 million

CardioNova/Russia/Maxwell Biotech/$1–5 million

Hepatera/Russia/Maxwell Biotech/$1–5 million

Infectex/Russia/Maxwell Biotech/$1–5 million

MetaMax/Russia/Maxwell Biotech/$1–5 million

EXAMPLES OF ACTIVITIES OF SPECIAL INTEREST TO RUSNANO:

BIND Biosciences (Cambridge, Mass.): Development in Russia of therapeutic nanoparticles for use in addressing solid tumors, inflammatory, and cardiovascular diseases. http://www.bindbio.com/content/pages/company/aboutrussia.jsp

Selecta Biosciences (Watertown, Mass.): Development in Russia of synthetic vaccine nanoparticles that encapsulate adjuvant and either a T-cell epitope or allergen in a polylactic acid-co-glycolic acid core surrounded by a lipid monolayer and a PEG shell decorated with a B-cell epitope.

Panacela Labs (Buffalo, N.Y.): A 4-year venture between Rusnano ($9 million) and Cleveland BioLabs ($3 million) for an oncology subsidiary.

BiOptix Diagnostics (Boulder, Colo.): Development of a surface plasmon-enhanced interferometer-detector for label-free bioassays.

http://cen.acs.org/articles/90/i16/Russian-Investors-Bankroll-biotech.html?h=1167136384. Accessed July 7, 2012.

Suggested Citation:"Appendix E.5: Rusnano and Other Russian Investors." National Research Council. 2013. The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions. Washington, DC: The National Academies Press. doi: 10.17226/18277.
×
Page 221
Suggested Citation:"Appendix E.5: Rusnano and Other Russian Investors." National Research Council. 2013. The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions. Washington, DC: The National Academies Press. doi: 10.17226/18277.
×
Page 222
Next: Appendix F: Other Topics of Interest »
The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions Get This Book
×
Buy Paperback | $54.00 Buy Ebook | $43.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

In the fall of 2010, the U.S. National Academies (consisting of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine) and the Russian Academy of Sciences (in cooperation with the Russian Academy of Medical Sciences and the Russian Academy of Agricultural Sciences) initiated a joint study of U.S.-Russian bilateral engagement in the biological sciences and biotechnology (hereinafter collectively referred to as bioengagement). The U.S. Department of State and the Russian Academy of Sciences provided support for the study. The academies established a joint committee of 12 leading scientists from the two countries to assess bioengagement activities since 1996 and to provide recommendations as to collaborative efforts in the near future. The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions summarizes the principal conclusions and recommendations of the study.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!